This included hyperglycemia, dyslipidemia (elevated TG and reduced HDL), oxidative stress (increased plasma 7α- and 7β-hydroxycholesterol), and heightened inflammation markers (hs-CRP and IL-1β) in the T2DM group. The gene discussed is IL1B; the disease is type 2 diabetes mellitus.